Patent ID: 11862337
Assignee: CAMBRIDGE COGNITION LIMITED
Field: Medical technology (Instruments)
Classification: CPC G  A | IPC A  G

Claim 7:
8. The method of claim 1, wherein the anti-psychotic drug comprises Chlorpromazine, Haloperidol, Loxapine, Perphenazine, Prochlorperazine, Thiothixene, Thioridazine, Trifluoperazine, Olanzapine, Paliperidone, Quetiapine, Risperidone, or Aripiprazole; and
the pro-cognitive drug is an agonist, an antagonist, a partial agonist, a positive allosteric modulator, a negative allosteric modulator, a silent allosteric modulator, or an inverse agonist of an ionotropphic receptor, a metabotrophic receptor, or a phosphodiesterase (PDE).